Peter Johnson

Also affiliated with University Hospital Southampton NHS Foundation Trust, NIHR CRUK Experimental Cancer Medicine Centre, University of Southampton

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Discovering dominant tumor immune archetypes in a pan-cancer census”.

Discovering dominant tumor immune archetypes in a pan-cancer census

Cell(2021)10.1016/j.cell.2021.12.004

N/A

4.2DataRank · unranked

176 citations

Bushra Samad, Jessica Tsui, Nayvin W. Chew, Peter Yan, Gabriella C. Reeder +75 more

KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.06.30.177477

N/A

0.208DataRank · unranked

3 citations

Lola Konali, Annalisa D’Avola, Karina Close, Alison Yeomans, Martin Philpott +21 more

Comparison of immunohistochemistry and gene expression profiling subtyping for diffuse large B‐cell lymphoma in the phase III clinical trial of R‐CHOP ± ibrutinib

British Journal of Haematology(2021)10.1111/bjh.17450

N/A

0DataRank · unranked

12 citations

Songbai Wang, Christopher Major, Brendan P. Hodkinson, Michael Schäffer, Laurie H. Sehn +10 more

126 | THE EARLY‐STAGE CLASSIC HODGKIN LYMPHOMA INTERNATIONAL PROGNOSTICATION INDEX (E‐HIPI): AN INDIVIDUALIZED PREDICTION MODEL UTILIZING OBJECTIVE AND CONTINUOUS VARIABLES

Hematological Oncology(2025)10.1002/hon.70093_126

N/A

0DataRank · unranked

0 citations

Angie May Rodday, Matthew J. Maurer, Jenica Upshaw, Nicholas Counsell, Sabrina Rossetti +19 more